Compounds > catechin

catechin and Seizures

catechin has been researched along with Seizures in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auladell, C; Barenys, M; Calpena, AC; Camins, A; Cano, A; Espina, M; Ettcheto, M; Folch, J; García, ML; Sánchez-López, E1
Cui, Z; Jia, L; Qu, Z; Si, P; Sun, C; Wang, W; Xie, T; Xue, Y; Zhen, J1
Adamo, EB; Altavilla, D; Bitto, A; Calò, M; Galfo, F; Interdonato, M; Irrera, N; Marini, H; Minutoli, L; Pallio, G; Pizzino, G; Rinaldi, M; Squadrito, F; Trichilo, V1
Rensing, NR; Wong, M; Yang, M; Zhang, B; Zou, J1
Jia, LJ; Kan, MC; Luan, SQ; Mao, ZF; Qu, ZZ; Wang, WP; Xie, T1
Park, KK; Reuben, JS; Soliman, KF1

Other Studies

6 other study(ies) available for catechin and Seizures

ArticleYear
Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy.
    Nanomedicine : nanotechnology, biology, and medicine, 2018, Volume: 14, Issue:4

    Topics: Animals; Catechin; Drug Carriers; Emulsions; Epilepsy, Temporal Lobe; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; PC12 Cells; Polyethylene Glycols; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Seizures

2018
(-)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Mar-07, Volume: 25

    Topics: Animals; Catechin; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Hippocampus; Lithium; Long-Term Potentiation; Male; Neurons; Neuroprotective Agents; NF-kappa B; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Signal Transduction; Toll-Like Receptor 4

2019
A dual inhibitor of cyclooxygenase and 5-lipoxygenase protects against kainic acid-induced brain injury.
    Neuromolecular medicine, 2015, Volume: 17, Issue:2

    Topics: Animals; Behavior, Animal; Brain Edema; Catechin; Cyclooxygenase Inhibitors; Dinoprostone; Drug Combinations; Hippocampus; Kainic Acid; Leukotriene B4; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Malondialdehyde; MAP Kinase Signaling System; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; Phosphorylation; Protein Processing, Post-Translational; Random Allocation; Rats; Rats, Sprague-Dawley; Seizures; Tumor Necrosis Factor-alpha

2015
Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.
    Neurobiology of disease, 2015, Volume: 80

    Topics: Animals; Anti-Inflammatory Agents; Catechin; Encephalitis; Hippocampus; Inflammation Mediators; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Multiprotein Complexes; Neocortex; Neuroglia; Seizures; Sirolimus; Survival Analysis; TOR Serine-Threonine Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tumor Suppressor Proteins

2015
Effects of epigallocatechin-3-gallate on pentylenetetrazole-induced kindling, cognitive impairment and oxidative stress in rats.
    Neuroscience letters, 2012, May-16, Volume: 516, Issue:2

    Topics: Animals; Brain; Catechin; Cognition; Convulsants; Kindling, Neurologic; Male; Maze Learning; Neuroprotective Agents; Oxidative Stress; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; Seizures

2012
The role of inducible-nitric oxide in cocaine-induced kindling.
    Experimental biology and medicine (Maywood, N.J.), 2001, Volume: 226, Issue:3

    Topics: Animals; Catechin; Cocaine; Convulsants; Hippocampus; Kindling, Neurologic; Lysine; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Seizures

2001